Search the site

ISSUE OF DEBT - NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA (OR TO U.S. PERSONS), AUSTRALIA, CANADA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.

This Trading Statement covers the period from 1 April 2015 to 30 June 2015, which is the first quarter of the financial year.

London, August 18 2015 – Tate & Lyle Ventures announces a $2 million investment in Evolve BioSystems, Inc. a microbiome spin-out company from the University of California at Davis.

Tate & Lyle Launches New Resource to Help Food and Beverage Manufacturers Unlock the Benefits of Fibre. New website features a suite of information for healthier and tastier fibre formulations.

London, 15 September 2015 – Tate & Lyle Ventures announced today that its Fund I portfolio company Lumora Ltd has been sold to ERBA Diagnostics Mannheim GmbH (ERBA), a global in vitro diagnostics company.

Tate & Lyle PLC (Tate & Lyle) announces that Judgment was handed down today at the Commercial Court in London in the case brought by American Sugar Refining, Inc. (“ASR”) in which it made a number of claims totalling around £40 million in relation to…

Release of the trading update for the six months to 30 September 2015 shows the Group is performing in line with expectations.

See link below for comparative financial information reflecting the re-alignment of the Eaststarch joint venture and the adoption of equity accounting.

Completion of re-alignment transaction for Eaststarch corn wet milling joint venture.